Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cognitive decline in Dutch-type hereditary and sporadic cerebral amyloid angiopathy: a 5-year follow-up study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease.

Journal of neurochemistry·2026
Same author

Country-specific modifiable dementia risk factors across the Western Pacific Region determined by population attributable fraction.

The Lancet regional health. Western Pacific·2026
Same author

Protocol for a Pre-Post Field Trial of a Home Hearing and Vision Care Program for Older Australians With Diverse Cognitive Abilities and Hearing and/or Vision Impairment.

Health science reports·2026
Same author

Dietary Patterns and Cerebral Glucose Metabolism in Older Adults: Findings from the Western Australian Memory Study.

Nutrients·2026
Same author

Composite scores to detect and monitor cognitive dysfunction in preclinical and prodromal Alzheimer's disease: A narrative review.

Journal of Alzheimer's disease : JAD·2026
Same journal

Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Greater choroid plexus volume is linked to poor sleep, neurodegeneration, and cognitive deficits in older adults: Evidence from the IGNITE Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Plasma-based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India - Diagnostic assessment of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Neuropathology-specific language features in primary progressive aphasia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Dementia blood biomarkers in the context of post-stroke cognitive outcomes: Systematic review and evidence synthesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Tahmida Sharmin1,2, Pratishtha Chatterjee1,3, James D Doecke4,5

  • 1Macquarie Medical School, Macquarie University, Macquarie Park, NSW, Australia.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

在具有β-粉样蛋白斑块的认知正常个体中,较高的血总Tau与增加的脊髓菌素有关,这表明早期的阿尔茨海默病途径参与. 这些基米林与粉样β负载相反相关,可能表明有补偿机制.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生化学
  • 脂质代谢 脂质代谢是什么

背景情况:

  • 血基米林水平的变化与阿尔茨海默病 (AD) 有关,这表明在病原发生过程中存在脂质代谢中断.
  • 血总Tau反映了AD中的神经元损伤和神经退行.
  • 通过在症状前研究基米林代谢和陶释放,可以了解阿尔茨海默病的生化途径.

研究的目的:

  • 在认知上正常的个体中探索血脊髓水平和总Tau之间的关系.
  • 检查在前症状阿尔茨海默氏症中基胺,总Tau和皮质粉样蛋白-β (Aβ) 负载之间的相关性.
  • 为了识别潜在的早期生物标志物为AD的发病因子.

主要方法:

  • 用针对性质谱分析分析的血样本用于斯芬戈米林和单分子阵列 (Simoa) 总Tau.
  • 该研究包括来自KARVIAH队列的100名认知正常 (CN) 个体,按皮质Aβ负载 (CN Aβ-和CN Aβ+) 分类.
  • 评估了横截面相关性,控制混变量并应用错误发现率 (FDR) 校正.

主要成果:

  • 仅在CN Aβ+个体中发现了基米林和总Tau之间的显著正相关性.
  • 这些关联在调整混因素和FDR纠正后仍然强.
  • 在CN Aβ+个体中,与总Tau相关的斯芬戈米林与皮质Aβ负荷有显著的反相关性.

结论:

  • 血总Tau的升高与患有Aβ斑块的预症状阿尔茨海默氏症患者的高米林相关,将tau释放与米林通路联系起来.
  • 较高水平的总Tau相关的米林与较低的皮质Aβ负载相关,可能反映了早期的补偿机制.
  • 总-Tau相关的甲基氨酸可以作为潜在的生物标志物,以了解症状前的AD机制.